Moreover, Epo administration to patients with MM and myelodysplastic syndrome induced BM angiogenesis and further malignant transformation in plasma cell leukemia and acute monoblastic leukemia, respectively [27, 28]. This evidence concerns the gene EPO and Miyoshi myopathy.